- Report
- January 2022
- 151 Pages
Global
From €4232EUR$4,799USD£3,664GBP
- Report
- September 2023
- 249 Pages
Global
From €4723EUR$5,542USD£3,950GBP
- Report
- December 2022
- 437 Pages
Global
From €4723EUR$5,542USD£3,950GBP
- Report
- April 2024
- 305 Pages
Global
From €5201EUR$6,103USD£4,350GBP
- Report
- September 2025
Global
From €300EUR$364USD£269GBP
- Report
- September 2025
Global
From €300EUR$364USD£269GBP
- Report
- February 2023
- 96 Pages
Global
From €1800EUR$2,186USD£1,613GBP
- Report
- September 2025
Global
From €300EUR$364USD£269GBP
- Report
- September 2025
Global
From €300EUR$364USD£269GBP
- Report
- September 2025
Global
From €300EUR$364USD£269GBP
- Report
- August 2023
- 267 Pages
Global
From €2150EUR$2,611USD£1,926GBP
- Report
- June 2022
- 115 Pages
Global
From €1050EUR$1,275USD£941GBP
- Report
- May 2022
- 50 Pages
Global
From €500EUR$607USD£448GBP
- Report
- May 2022
- 32 Pages
Global
From €400EUR$486USD£358GBP
- Report
- October 2021
- 433 Pages
Global
From €2250EUR$2,733USD£2,016GBP
- Report
- December 2019
- 59 Pages
Global
From €3528EUR$4,000USD£3,054GBP
- Report
- July 2024
- 266 Pages
Global
From €4366EUR$4,950USD£3,779GBP
- Report
- July 2024
- 335 Pages
Global
From €4366EUR$4,950USD£3,779GBP
- Report
- April 2024
- 270 Pages
Global
From €4410EUR$5,000USD£3,817GBP
- Report
- February 2022
- 272 Pages
Global
From €5292EUR$6,000USD£4,581GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more